UBS AM
LFMD icon

UBS AM’s LifeMD LFMD Stock Holding History

UBS AM’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Hold
261
– – ﹤0.01% 3606
2026
Q1 		$942 Buy
+261
New +$903 ﹤0.01% 3684

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS AM's LFMD Position: Q2 2026 in Review

UBS AM held its LifeMD (LFMD) position steady in Q2 2026 at 261 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

UBS AM first reported a position in LFMD in Q1 2026 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • UBS AM held 261 shares of LifeMD worth $1.08K as of Q2 2026.
  • UBS AM left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3606 holding.
  • UBS AM first reported a position in LifeMD in Q1 2026 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.